Your session is about to expire
← Back to Search
Real-world vibration feedback gait retraining for Chronic Ankle Instability (RWVF Trial)
RWVF Trial Summary
This trial is testing whether two weeks of gait retraining with vibration feedback can restore normal walking mechanics in people with chronic ankle instability, which causes abnormal walking that can lead to lifelong disability.
RWVF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RWVF Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants does this trial have a capacity for?
"Affirmative. According to data hosted on clinicaltrials.gov, this medical trial is actively recruiting patients since its initial posting date of June 9th 2022 and latest edit on August 15th 2022. The study requires 20 participants from one location."
Are recruitment efforts ongoing for this research endeavor?
"As indicated on clinicaltrials.gov, this investigation is presently looking for suitable participants and was initially posted June 9th 2022, with the most recent update having occurred August 15th of the same year."
Who is eligible to join the trial cohort?
"This clinical investigation is recruiting 20 young adults aged 18-35 who have articulated ankle instability. To qualify, they must additionally score ≥ 11 on the Identification of Functional Ankle Instability (IdFAI) and report functional limitations with a FAAM Activities of Daily Living subscale rating < 90% and Sport subscale reading below 80%. Additionally, their joint instability must be attributable to at least one major sprain occurring over 12 months before enrolling."
Are individuals aged under 70 eligible for enrollment in this experiment?
"This trial has established that participants should be between 18 and 35 years of age. There are also 3 studies dedicated to those under the legal age, as well as 6 trials for patients over 65 years old."
Share this study with friends
Copy Link
Messenger